Literature DB >> 3876736

Intraarterial prednisolone infusion therapy in ulcerative colitis.

S Momoshima, E Kohda, K Hiramatsu, H Asakura.   

Abstract

Thirty-seven patients with ulcerative colitis who had shown inadequate response to conventional medical therapies were given intraarterial infusions of prednisolone via the superior and inferior mesenteric arteries. The therapy was effective in 31 (57%) of 54 infusions, including three of five cases of toxic megacolon. The effectiveness of the therapy correlated well with the clinical assessment of disease activity. There was also a positive correlation between the caliber of the inferior mesenteric artery and the effectiveness of the therapy. Intraarterial infusion of prednisolone can lead to improvement of ulcerative colitis, and this mode of therapy should be considered particularly in severe cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876736     DOI: 10.2214/ajr.145.5.1057

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.

Authors:  Koji Sawada; Akimitsu Egashira; Kunio Ohnishi; Ken Fukunaga; Takeshi Kusaka; Takashi Shimoyama
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

2.  A successful case of intraarterial prednisolone injection therapy in severe ulcerative colitis unresponsive to an intensive intravenous regimen.

Authors:  N Ishii; M Chiba; T Suzuki; M Iizuka; O Masamune; N Kubo
Journal:  Gastroenterol Jpn       Date:  1993-10

3.  Hemorrhagic radiation gastritis successfully treated with repeated intra-arterial steroid infusions.

Authors:  Kazuhito Kawata; Yoshimasa Kobayashi; Kenichi Souda; Kinya Kawamura; Yurimi Takahashi; Hidenao Noritake; Shinya Watanabe; Tomoyuki Suehiro; Mika Kamiya; Shuhei Yamashita; Takasuke Ushio; Hirotoshi Nakamura
Journal:  Clin J Gastroenterol       Date:  2010-12-10

4.  Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease.

Authors:  Aynur Uğur Bilgin; Pervin Topcuoğlu; Tanzer Sancak; Nahide Konuk; Mutlu Arat
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

5.  Activation of GPR35 protects against cerebral ischemia by recruiting monocyte-derived macrophages.

Authors:  Ozayra Sharmin; Ariful Haque Abir; Abdullah Potol; Mahabub Alam; Jewel Banik; A F M Towheedur Rahman; Nuzhat Tarannum; Rasiqh Wadud; Zaki Farhad Habib; Mahbubur Rahman
Journal:  Sci Rep       Date:  2020-06-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.